Translational research of ghrelin

Annals of the New York Academy of Sciences
Hiroaki UenoMasamitsu Nakazato

Abstract

Gastrointestinal peptides play important roles regulating feeding and energy homeostasis. Most gastrointestinal peptides including glucagon like peptide-1, peptide YY, amylin, and oxytomodulin are anorectic, and only ghrelin is an orexigenic peptide. Ghrelin increases appetite, modulates energy balance, suppresses inflammation, and enhances growth hormone secretion. Given its diversity of functions, ghrelin is expected be an effective therapy for lean patients with cachexia caused by chronic heart failure, chronic respiratory disease, anorexia nervosa, functional dyspepsia, and cancer. Clinical trials have demonstrated that ghrelin effectively increases lean body mass and activity in cachectic patients. Ghrelin interrupts the vicious cycle of the cachectic paradigm through its orexigenic, anabolic, and anti-inflammatory effects, and ghrelin administration may improve the quality of life of cachectic patients. We discuss the significant roles of ghrelin in the pathophysiology of cachectic diseases and the possible clinical applications of ghrelin.

Associated Clinical Trials

References

Dec 8, 1994·The New England Journal of Medicine·G W Dec, V Fuster
Dec 12, 1997·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·R MarcénC Gámez
Aug 26, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H J AndreyevD Cunningham
Nov 1, 2000·Nature·M TschöpM L Heiman
Jan 3, 2001·The Journal of Clinical Endocrinology and Metabolism·K TakayaK Nakao
Feb 13, 2001·Biochemical and Biophysical Research Communications·Y DateS Matsukura
Feb 24, 2001·Nature·M NakazatoS Matsukura
Apr 11, 2001·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·N NagayaK Kangawa
Nov 29, 2001·The Journal of Biological Chemistry·Masahiro MurataKazuo Chihara
Dec 12, 2001·The Journal of Clinical Endocrinology and Metabolism·N NagayaK Kangawa
Dec 12, 2001·The Journal of Clinical Endocrinology and Metabolism·A M WrenS R Bloom
Jan 15, 2002·The Journal of Clinical Endocrinology and Metabolism·Tomomi ShiiyaShigeru Matsukura
May 23, 2002·American Journal of Physiology. Gastrointestinal and Liver Physiology·L TrudelP Poitras
Jun 7, 2002·The Journal of Clinical Endocrinology and Metabolism·Sharmilee GnanapavanMárta Korbonits
Jan 28, 2003·The American Journal of Pathology·Marco VolanteMauro Papotti
Feb 5, 2003·Biochemical and Biophysical Research Communications·Takeshi HanadaMasamitsu Nakazato
Sep 3, 2003·Biochemical and Biophysical Research Communications·Mark S DuxburyEdward E Whang
Jun 8, 2004·The Journal of Clinical Endocrinology and Metabolism·Nicola M NearyStephen R Bloom
Jul 3, 2004·The Journal of Clinical Investigation·Vishwa Deep DixitDennis D Taub
Jul 24, 2004·American Journal of Respiratory and Critical Care Medicine·Takefumi ItohHiroshi Kimura
Aug 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·Steffen HelmlingSven Klussmann
Oct 14, 2004·Gastroenterology·Jan TackGiovanni Sarnelli
Nov 9, 2004·The Journal of Clinical Endocrinology and Metabolism·Mari HottaKazue Takano
Sep 16, 2005·Chest·Noritoshi NagayaKenji Kangawa
Sep 27, 2005·The Journal of Surgical Research·Ko TakachiShingi Imaoka
Oct 18, 2005·Alimentary Pharmacology & Therapeutics·J TackT Peeters
Dec 3, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Anthony H YehLisa K Chopin
Oct 26, 2006·The Journal of Clinical Endocrinology and Metabolism·Philippe Le CorvoisierPatrick Maison
Nov 18, 2006·Mechanisms of Ageing and Development·Koji ToshinaiMasamitsu Nakazato
Jul 14, 2007·American Journal of Respiratory and Critical Care Medicine·Rongqian WuPing Wang

❮ Previous
Next ❯

Citations

Apr 7, 2012·Endocrine·Amy C EllisBarbara A Gower
Mar 1, 2011·Therapeutic Advances in Chronic Disease·Orla F Craig, Eamonn M M Quigley
Mar 6, 2012·Regulatory Peptides·Amy C EllisBarbara A Gower
Apr 5, 2011·Molecular and Cellular Endocrinology·Penny JefferyMichael McGuckin
Mar 12, 2011·The Veterinary Clinics of North America. Equine Practice·Ramiro E Toribio
Feb 2, 2011·Pediatric Clinics of North America·Donald E GreydanusCynthia Feucht
Mar 8, 2011·Peptides·Renato N SorianoLuiz G S Branco
Feb 26, 2014·Current Opinion in Pharmacology·Sergio Melotto
Jul 23, 2016·Frontiers in Neuroscience·Philip GorwoodJacques Epelbaum
Aug 4, 2016·European Journal of Internal Medicine·Giovanni VitaleDaniela Mari
Jul 30, 2011·JPEN. Journal of Parenteral and Enteral Nutrition·Daniel Crona, Robert MacLaren
Nov 5, 2014·Surgery Today·Shuji TakiguchiYuichiro Doki
Sep 25, 2016·Current Diabetes Reports·Michael A GrandnerSundeep Shenoy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anorexia Nervosa

Anorexia nervosa (AN) is a psychiatric condition characterized by severe weight loss and secondary problems associated with malnutrition. Here is the latest research on AN.

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here